These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 8997556

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phenotypic variation and antifungal susceptibility patterns of Candida albicans strains isolated from neutropenic patients.
    Kiraz N, Anğ O, Akgün Y, Erturan Z.
    Mycoses; 2000; 43(3-4):119-23. PubMed ID: 10907341
    [Abstract] [Full Text] [Related]

  • 3. In vitro investigation of antifungal activities of phenotypic variation Candida albicans strains against fluconazole, itraconazole and voriconazole.
    Cetinkaya Z, Kiraz N.
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(3):197-201. PubMed ID: 16094296
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents.
    Arias A, Arévalo MP, Andreu A, Rodríguez C, Sierra A.
    Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans].
    Zhang X, Liu ZH.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr 25; 51(4):279-84. PubMed ID: 27116986
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro susceptibility of Candida spp. to fluconazole, itraconazole and voriconazole and the correlation between triazoles susceptibility: Results from a five-year study.
    Lei J, Xu J, Wang T.
    J Mycol Med; 2018 Jun 25; 28(2):310-313. PubMed ID: 29685520
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
    Colombo AL, Nakagawa Z, Valdetaro F, Branchini ML, Kussano EJ, Nucci M.
    Med Mycol; 2003 Jun 25; 41(3):235-9. PubMed ID: 12964715
    [Abstract] [Full Text] [Related]

  • 12. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 25; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A, Yacouba A, Bamba S, Sangare I, Sawadogo M, Guiguemde T, Kone S, Traore LK, Ouedraogo-Traore R, Guiguemde RT.
    J Mycol Med; 2017 Dec 25; 27(4):469-475. PubMed ID: 28754462
    [Abstract] [Full Text] [Related]

  • 15. Azole resistance in neonatal intensive care units in Argentina.
    Giusiano G, Mangiaterra M, Rojas F, Gómez V.
    J Chemother; 2005 Jun 25; 17(3):347-50. PubMed ID: 16038532
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
    Zhao M, Zhou ZT.
    Shanghai Kou Qiang Yi Xue; 2006 Apr 25; 15(2):218-20. PubMed ID: 16685371
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility to itraconazole and fluconazole of switch phenotypes of Candida albicans serotypes A and B, isolated from immunocompromised hosts.
    Velegraki A.
    J Med Vet Mycol; 1995 Apr 25; 33(1):83-5. PubMed ID: 7650586
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.